Appeals : Confirmed
Referee Decisions : #63 - October 15, 2002
D E C I S I O N
Background:
The Estate of the Claimant, (the "Estate") submitted
an application for compensation under the 1986-1990 Hepatitis
C Settlement Agreement (the "Agreement") and Schedule
A - The Transfused HCV Plan, (the "Plan").
By letter dated October 30, 2001, the Administrator of the
Fund (the "Administrator") denied the claim on the
basis there was insufficient evidence that the death of the
Claimant was caused by his infection with Hepatitis C ("HCV").
The Estate requested that a Referee review the decision of
the Administrator in an oral hearing.
Evidence:
The following facts were not in dispute:
- The Claimant was infected with HCV;
- The Claimant died on October 31, 1998, of multiple trauma
resulting from a motor vehicle accident; and,
- The Claimant's treating physician indicated on the TRAN
2 form that the Claimant's HCV infection did not materially
contribute to his death.
Both the Claimant's mother and son testified at the hearing.
It was clear from their evidence that the Claimant's infection
with HCV dramatically diminished both his quality of life
and their ability to enjoy his companionship. In addition,
his inability to work as his condition deteriorated created
serious financial difficulty for his family.
The Claimant's treating physician also testified at the hearing.
He was the Claimant's family physician from 1992 until the
Claimant's death. The physician described the deterioration
in the Claimant's condition from the time he was diagnosed
with HCV in 1993 to shortly before his accident.
The Claimant was last seen by his physician approximately
one month prior to his death. At that time, the Claimant was
feeling optimistic regarding his condition and was considering
returning to work. While the physician felt this was unrealistic,
he also testified that the Claimant might have lived for another
ten years as death from HCV is unpredictable.
Applicable Provisions of the Plan:
5.01 Compensation if Deceased Prior to 1 January 1999
(1) If a HCV Infected Person died prior to 1 January 1999
and his or her HCV Personal Representative delivers to the
Administrator the evidence required under Article Three within
the period set out in Section 3.05, the Approved HCV Personal
Representative is entitled to be reimbursed for the uninsured
funeral expenses incurred up to a maximum of $5,000 and, subject
to the provisions of Section 5.01(2), the Approved HCV Personal
Representative will be paid the amount of $50,000 in full
satisfaction of any and all Claims that the HCV Infected Person
would have had under this Plan if he or she had been alive
on or after 1 January 1999. This $50,000 payment to the Approved
HCV Personal Representative is in addition to the Claims of
Dependants and other Family Members pursuant to Article Six
and will not affect the personal Claim of a Spouse or Child
who is also a HCV Infected Person...[emphasis added]
6.01 Compensation to Approved Dependants
(1) If a HCV Infected Person dies and the death was caused
by his or her infection with HCV, the Approved Dependants
of such HCV Infected Person will be entitled to be compensated
for their loss of support. The loss of support is an amount
each calendar year equal to 70% of the deceased HCV Infected
Person's Annual Loss of Net Income for such year until he
or she would have attained the age of 65 years determined
in accordance with 4.02(2), provided, however, that the annual
amount payable under this provision will be reduced by an
amount equal to 30% of the net amount as calculated to allow
for the personal living expenses of the HCV Infected Person,
and provided further that, for purposes of calculating the
annual amount payable under this provision, "Post-claim
Net Income" will be computed without reference to clauses
(A), (C) and (D) of the definition of "Post-claim Net
Income" and that the words "the person" and
"on account of illness or disability for the year"
in clause (B) and the words "the person" in clause
(E) of the definition of "Post-claim Net Income"
were replaced with the words "the Dependants as a result
of the death of the person". [emphasis added]
3.05 Claim by HCV Personal Representative of HCV Infected
Person
(1) A person claiming to be the HCV Personal Representative
of a HCV Infected Person who has died must deliver to the
Administrator, within three years after the death of such
HCV Infected Person or within two years after the Approval
Date, whichever event is the last to occur, an application
form prescribed by the Administrator together with:
(a) proof that the death of the HCV Infected Person was
caused by his or her infection with HCV; [emphasis added]
3.06 Claim by Dependant
A person claiming to be a Dependant of a HCV Infected Person
who has died must deliver to the Administrator, within two
years after the death of such HCV Infected Person or within
two years after the Approval Date or within one year of the
claimant attaining his or her age of majority, whichever event
is the last to occur, an application form prescribed by the
Administrator together with:
(a) proof as required by Sections 3.05(1)(a) and (b) (or,
if applicable, Section 3.05(3) or (4)) and 3.05(5) and (6),
unless the required proof has been previously delivered to
the Administrator; ... [emphasis added]
3.07 Claim by Family Member
A person claiming to be a Family Member referred to in clause
(a) of the definition of Family Member in Section 1.01 of
a HCV Infected Person who has died must deliver to the Administrator,
within two years after the death of such HCV Infected Person
or within two years after the Approval Date or within one
year of the claimant attaining his or her age of majority,
whichever event is the last to occur, an application form
prescribed by the Administrator together with:
(a) proof as required by Sections 3.05(1)(a) and (b) (or,
if applicable, Section 3.05(3) or (4)) and 3.05(5) and (6),
unless the required proof has been previously delivered to
the Administrator; ...[emphasis added]
Argument:
The Estate maintained that the Claimant had been infected
with HCV through a blood transfusion received following a
workplace accident on January 6, 1988. Consequently, the Estate
maintained that the accident in which the Claimant was killed
simply changed the date of his death - not the inevitability
of his death.
The Estate submitted that the claimant's family could bring
a claim pursuant to either Articles 5.01 and 6.01.
The Estate argued that nothing in Article 5.01 requires that
the Claimant's death have resulted from his infection with
HCV.
The Estate conceded that Article 6 expressly precludes a
claim unless it can be shown that the Claimant's death was
caused by his infection with HCV.
However, the Estate pointed out that both the Claimant and
the Claimant's family suffered as much as others in their
situation, and that it was inequitable that they could not
receive compensation pursuant to the settlement.
The Estate maintained that in light of the intent of the
plan, the date of death was not important for the purpose
of Article 6.01. Rather, the Estate maintained the issue was
whether the Claimant would have died as a result of his infection
with HCV had it not been for the intervening event of the
motor vehicle accident. The Estate argued that the Claimant's
death had been imminent because of his HCV.
The Administrator also pointed out that Article 5.01 expressly
requires the same evidence as required under Article Three
in order for entitlement to be established (see bold). Consequently,
the Administrator maintained that the requirements of Article
5 and 6 are the same in that they both require proof that
the Claimant's death was caused by his infection with HCV.
The Administrator also pointed out that despite the submission
of the Estate to the contrary, the Claimant's physician testified
that he may have lived an additional ten years. Consequently,
even if entitlement were based on proof of imminent death
from infection with HCV, that proof was lacking in this instance.
The Administrator also submitted that the provisions of the
Settlement and the Plan are clear in the parameters for entitlement
and that neither the Administrator nor a Referee have discretion
to vary them.
Analysis:
Article 6.01 clearly sets out the requirement for proof that
the Claimant's death was caused by his infection with HCV.
I find that Article 5.01 incorporates the same requirement
by reference to the evidence required under Article 3.
Article 3.05(1)(a) of the Agreement requires, as a threshold
test for a claim, proof that a claimant's death was caused
by his or her infection with HCV. This requirement is further
affirmed by Articles 3.06 and 3.07.
The Estate, therefore, must establish that the Claimant's
death was caused by his infection with HCV.
The Estate has not provided any proof that the death of the
Claimant was caused by his infection with HCV. Rather, the
evidence clearly established that his death was the result
of a motor vehicle accident, and I so find.
This is regrettable for the Claimant's family as it is clear
they have suffered greatly as a result of the Claimant's infection
with HCV.
However, neither the Administrator nor I, as a Referee, have
any discretion to grant compensation in circumstances where
the death of an HCV infected person cannot be attributed to
that infection.
Accordingly, I find that the Administrator correctly determined
that the Estate of the Claimant is not entitled to compensation
pursuant to the Agreement, as his death did not result from
his having been infected with HCV.
Determination:
The decision of the Administrator to deny the Estate of the
Claimant compensation pursuant to the Hepatitis C 1986-1990
Class Action Settlement Agreement is upheld.
DATED AT TORONTO, THIS 15TH DAY OF OCTOBER, 2002.
Tanja Wacyk, Referee
|